January 11-14, 2027 | San Francisco Marriott Marquis January 15, 2027 | Virtual
January 11-14, 2027 | San Francisco January 15, 2027 | Virtual
Corvus is a clinical stage company developing first-in-class, novel, oral, highly selective, ITK inhibitors for Immunology and Oncology.